Larimar Therapeutics, Inc. (LRMR)
3.83
0.00 (0.00%)
USD |
NASDAQ |
Sep 04, 16:00
3.85
+0.02
(+0.52%)
After-Hours: 20:00
Larimar Therapeutics Free Cash Flow : -156.08M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -156.08M |
| March 31, 2026 | -131.32M |
| December 31, 2025 | -113.29M |
| September 30, 2025 | -96.76M |
| June 30, 2025 | -92.59M |
| March 31, 2025 | -87.45M |
| December 31, 2024 | -71.28M |
| September 30, 2024 | -58.79M |
| June 30, 2024 | -43.38M |
| March 31, 2024 | -36.48M |
| December 31, 2023 | -33.62M |
| September 30, 2023 | -30.79M |
| June 30, 2023 | -27.47M |
| March 31, 2023 | -27.69M |
| December 31, 2022 | -27.67M |
| September 30, 2022 | -28.92M |
| June 30, 2022 | -35.54M |
| March 31, 2022 | -38.76M |
| December 31, 2021 | -42.44M |
| September 30, 2021 | -44.37M |
| June 30, 2021 | -43.11M |
| March 31, 2021 | -44.50M |
| December 31, 2020 | -42.27M |
| September 30, 2020 | -40.38M |
| Date | Value |
|---|---|
| June 30, 2020 | -34.96M |
| March 31, 2020 | -19.29M |
| December 31, 2019 | -22.78M |
| September 30, 2019 | -26.67M |
| June 30, 2019 | -34.00M |
| March 31, 2019 | -50.80M |
| December 31, 2018 | -51.60M |
| September 30, 2018 | -49.61M |
| June 30, 2018 | -48.56M |
| March 31, 2018 | -45.42M |
| December 31, 2017 | -43.84M |
| September 30, 2017 | -42.64M |
| June 30, 2017 | -41.57M |
| March 31, 2017 | -46.16M |
| December 31, 2016 | -52.64M |
| September 30, 2016 | -62.28M |
| June 30, 2016 | -67.46M |
| March 31, 2016 | -67.20M |
| December 31, 2015 | -60.15M |
| September 30, 2015 | -53.56M |
| June 30, 2015 | -43.66M |
| March 31, 2015 | -35.39M |
| December 31, 2014 | -28.30M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| SELLAS Life Sciences Group, Inc. | -28.42M |
| Marker Therapeutics, Inc. | -9.756M |
| Rezolute, Inc. | -73.48M |
| Krystal Biotech, Inc. | 257.78M |
| ACADIA Pharmaceuticals, Inc. | 145.62M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -44.03M |
| Cash from Investing (Quarterly) | -40.91M |
| Cash from Financing (Quarterly) | -0.435M |
| Free Cash Flow Per Share (Quarterly) | -0.4231 |
| Free Cash Flow to Equity (Quarterly) | -45.34M |
| Free Cash Flow to Firm (Quarterly) | -44.16M |
| Free Cash Flow Yield | -45.48% |